UnicomIG
0.1.0 - ci-build
UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/tree/master and changes regularly. See the Directory of published versions
Full name: Clexane, 6000 RÜ (60 mg)/0,6 ml süstelahus süstlis
- Invented name part: Clexane
- Strength part: 6000 RÜ
- Pharmaceutical dose form part: süstelahus süstlis
Name usage: Estonian (Republic of Estonia)
Authorised dose form: Solution for injection
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 940517
Region: Republic of Estonia
Marketing authorisation holder: Sanofi-Aventis Groupe
Identifier:
Status: Valid - Renewed/Varied (2022-06-28)
Package 1 of 1
PCID: EE-100001368-34217-1065552
Description: CLEXANE 6000 RÜ (60 mg)/0,6 ml: süstelahus süstlites (I tüüpi klaas), mis on varustatud kummikorgiga (klorobutüül ja bromobutüül) ning süstimisnõelaga (automaatse ohutussüsteemiga ERIS või PREVENTIS või ilma).
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 2 Pre-filled syringe (Glass type I)
Containing: 0.6 millilitre(s)
Manufactured Item
Dose form: Solution for injection
Unit of presentation: Syringe
Ingredient
Role: Active
Substance: Enoxaparin sodium
Presentation strength: 60 milligram(s) / 0.6 millilitre(s)
Administrable Product (1 of 1)
Dose form: Solution for injection
Unit of presentation: Syringe
Route of administration:
Ingredient
Role: Active
Substance: Enoxaparin sodium
Presentation strength: 60 milligram(s) / 0.6 millilitre(s)